Abstract The purpose of this study was to demonstrate feasibility of percutaneous transluminal aortic stenting and cava filter placement under magnetic resonance imaging (MRI) guidance exclusively using a polyetheretherketone (PEEK)-based MRI-compatible guidewire. Percutaneous transluminal aortic stenting and cava filter placement were performed in 3 domestic swine. Procedures were performed under MRI-guidance in an open-bore 1.5-T scanner. The applied 0.035-inch guidewire has a PEEK core reinforced by fibres, floppy tip, hydrophilic coating, and paramagnetic markings for passive visualization. Through an 11F sheath, the guidewire was advanced into the abdominal (swine 1) or thoracic aorta (swine 2), and the stents were deployed. The guidewire was advanced into the inferior vena cava (swine 3), and the cava filter was deployed. Postmortem autopsy was performed. Procedural success, guidewire visibility, pushability, and stent support were qualitatively assessed by consensus. Procedure times were documented. Guidewire guidance into the abdominal and thoracic aortas and the inferior vena cava was successful. Stent deployments were successful in the abdominal (swine 1) and thoracic (swine 2) segments of the descending aorta. Cava filter positioning and deployment was successful. Autopsy documented good stent and filter positioning. Guidewire visibility through applied markers was rated acceptable for aortic stenting and good for venous filter placement. Steerability, pushability, and device support were good. The PEEK-based guidewire allows either percutaneous MRI-guided aortic stenting in the thoracic and abdominal segments of the descending aorta and filter placement in the inferior vena cava with acceptable to good device visibility and offers good steerability, pushability, and device support.
Introduction
Magnetic resonance imaging (MRI) provides excellent softtissue contrast and allows image acquisition and threedimensional reconstruction in any orientation. Compared with fluoroscopy, which is currently used for endovascular interventions, it lacks radiation exposure to the patient and staff and may be used without nephrotoxic contrast media. MRI's known ability to depict and/or quantify functional parameters (e.g., blood flow, diffusion, perfusion, etc.) may be used to determine the success of an endovascular intervention [1, 2] .
However, there have only been some reports on MRIguided endovascular intervention in the literature [1] [2] [3] [4] [5] . With modern open-bore MR-systems and fast sequences being available as well as MR-compatible stents, angioplasty balloons and non-braided catheters on the market, this has by most authors been attributed to the lack of an MR-compatible guidewire [6] .
In some animal studies, taking the risk of rapid in vivo heating and spark yielding into account, standard nitinol guidewires were used. Sometimes the entire procedure was performed without using a guidewire for device delivery [6] [7] [8] [9] [10] .
A concept of a MRI-compatible guidewire with a PEEK core was published, but until today the in vivo applicability of such passively marked PEEK-based guidewires has not been proven [11] .
The purpose of this study was to show the first in vivo use of an MRI-compatible 0.035-inch PEEK-based guidewire for MRI-guided thoracic and abdominal aortic stenting and cava filter placement in swine.
Materials and Methods

PEEK-Based Guidewire
A 0.035-inch, 160 cm-long MRI-compatible guidewire was used (Biotronik Vascular Intervention, Buelach, Switzerland). It has a central PEEK core (0.57-mm diameter) reinforced by fibres. This core compound is tapered (to 0.15 mm in diameter) at the distal 12 cm, thereby providing an atraumatic tip. The guidewire core is covered along its axis with a polyurethane jacket and a hydrophilic coating.
It provides passive MRI markings composed of paramagnetic alfa-Fe 3 O 4 nanoparticles (MagnaFy; MagnaMedics GmbH, Aachen, Germany) (Fig. 1) . These nanoparticles were applied on the wire in an adhesive coating, forming 0.03-mm thick and 1.5-mm broad markings. For aortic stenting, four distal markings were spaced by 20 mm. Two further markings were separated by 40 mm, enhancing visibility of the distal part of the guidewire shaft. For cava filter placement, 7 markers were attached, with the distal 5 markers being separated by 20 mm.
MR Imaging and MR Suite
A 1.5-T whole-body open-bore scanner (Espree; Siemens Healthcare, Erlangen, Germany) was used. With a high-performance gradient system (gradient strength 33 mT/ m; slew rate 100 T/m/s) and standard surface receiver coils, a gradient echo T1-FLASH sequence (BEAT-IRT) was used. Imaging parameters were as follows: field of view 400 9 358 mm; matrix size 288 9 172; voxel size 2.3 9 1.4 9 5.0 mm; TR 8.12 ms; TE 5.24 ms; flip angle 218; bandwidth 299 Hz/pixel. Images were displayed on an 18-inch monitor (Siemens Healthcare, Erlangen, Germany) mounted beside the MRI-scanner (frame rate 2/3 per second).
Before the intervention, a single intravenous injection of blood-pool contrast media gadofosveset (Vasovist; BayerSchering Pharma, Berlin, Germany) in a dosage of 0.03 mmol gadolinium (Gd)/kg body weight (bw) was administered to achieve better vascular depiction throughout the remainder of the procedures.
Animal Preparation
Animal experiments were conducted at the University Hospital Essen (Germany) according to the policies for the human care and use of animals. The procedures performed were approved by the Regional and Institutional Animal Care and Use Committee.
Three domestic pigs (60-70 kg bw) were prepared according to a previously published protocol [12] . Pigs were intubated using an 6.5-mm endotracheal tube and ventilation which was performed throughout the procedure by a respirator (Oxylog; Dräger, Lübeck, Germany). During the entire procedure, infusion anaesthesia was maintained by continuous administration of propofol, midazolam, and fentanyl.
After surgical preparation, 11F/10-cm catheter sheaths (Radiofocus Introducer II; Terumo, Leuwen, Belgium) were inserted in the iliac arteries and in the iliac vein. A heparin bolus (5,000 U) was given intravenously after sheath placement, and 1,000 U were given every hour consecutively. Animals were then placed supine and head first into the MRI scanner. 
MRI Intervention
Aortic stent placement and cava filter placement were performed by experienced interventional radiologists in all swine through the iliac catheter sheath and using MRI guidance as previously described.
Abdominal Aortic Stenting: Swine 1
Through the 11F vascular access sheath, the guidewire was advanced into the suprarenal segment of the descending aorta. Over the guidewire, a balloon (Pheron 10 mm/ 40 mm; Biotronik) was placed in the infrarenal abdominal aorta, followed by percutaneous transluminal angioplasty (PTA) through inflation of the balloon with 1-2 ml (0.025 mmol/l) Gd-DOTA (Dotarem; Guerbet, Roissy CDG Cedex, France). Thereafter, a self-expandable stent was positioned in the infrarenal abdominal aorta and deployed (Astron 10 mm/60 mm). A second balloon dilatation was performed within the stent (Pheron 10 mm/ 40 mm; Biotronik).
Thoracic Aortic Stenting: Swine 2
Through the left 11 vascular access sheath, the guidewire was advanced into the thoracic segment of the descending Through the venous iliac 11F access sheath, the guidewire was advanced 2 times into the hepatic segment of the inferior vena cava. Over the positioned guidewire, the filter's 6F (internal diameter), 90 cm-long introducer sheath OptEase; Retrievable Vena Cava Filter; Cordis Europe, Roden, The Netherlands) was advanced into inferior vena cava. Because of the atypically deep retroperitoneal position of the right kidney, the infrarenal segment of the inferior vena cava was short and did not allow filter placement below the renal veins. The sheath, which was marked only by a regular X-ray-absorbing marker at the tip, was therefore positioned twice in the hepatic segment of the inferior vena cava. Correct intravenous positioning of the sheath was documented by hand injection of a 10-ml bolus (0.05 mmol Gd/ml) Gd-DOTA (Dotarem). The guidewire was withdrawn and the selfcentering 6 diamond-shaped cava filter (Optease Retrievable Vena Cava Filter; Cordis Europe, Roden, The Netherlands) positioned and released in the hepatic segment of the inferior vena cava.
Procedure times were documented for the interventions in all swine. Success rates (2 grades: ±) of any procedure step were rated, and guidewire characteristics-such as visibility, pushability, steerability, and filter/balloon/stent support ( After the experiments, the swine were killed by intravenous injection of phenobarbital (80 mg/kg). The positions of the deployed stents and the cava filter were documented by postmortem autopsy.
Results
Aortic Stenting
Guidewire guidance into the targeted abdominal and thoracic aortic segments was successful (2 of 2). Over-the-wire placement and dilatation of the PTA balloon in the abdominal aorta was feasible before and after stent deployment (2 of 2). Over-the-wire positioning and release of self-expandable stents was successful (2 of 2) (Figs. 2, 3 ).
Postmortem autopsy showed good stent positioning and no evidence of traumatic vessel wall damage (Fig. 4) . Procedure times were 12 minutes for stenting of the thoracic aortic segment and 10 minutes for stenting of the abdominal aortic segment. The guidewire, its surface, and the applied passive marking macroscopically remained intact. There was no evidence of guidewire fracture or kinking. By consensus, guidewire visibility was rated acceptable (??) and guidewire pushability, steerability, and balloon/stent support were rated good (???).
Cava Filter Placement
Guidewire positioning in the hepatic segment of the inferior vena cava was successful as was placement of the cava filter's introducer sheath over the wire (Figs. 5, 6 ). After removal of the guidewire, positioning and release of the filter through the introducer sheath was successful. Postmortem autopsy showed good filter positioning in the hepatic segment of the inferior vena cava (Fig. 4) . Autopsy showed no evidence of traumatic vessel wall damage. Procedure times was 6 minutes. The PEEK-based guidewire and its passive markings remained intact, without macroscopic evidence of guidewire fracture or kinking. By consensus, guidewire visibility was rated good (???) and guidewire pushability and introducer sheath support were rated good (???).
Discussion
This results of this study demonstrate that MRI-guided stenting of the aorta and cava filter placement are feasible when using an MRI-compatible PEEK-based guidewire. Commercially available nonbraided catheters, PTA balloons, and stents may safely be used for MRI-guided endovascular interventions as shown earlier in different vascular territories. The first MRI-guided placement of a vena cava filter, which required 30 seconds for the acquisition of a single imaging slice, was described in 1997 [13] . With faster sequences available today, 2 more recent studies showed the feasibility cava filter placement in swine under real-time MRI-guidance [14, 15] . However, given the previously described advantages of MRI for the guidance of endovascular procedures, until today this promising technique has not been shown to be transferable to humans.
This can be explained, as such animal studies did not use a guidewire for procedure guidance, thereby increasing the risk to cause vessel dissection, perforation or rupture, or as a major drawback, observed sparking and guidewire heating in the magnetic field, when using standard nitinol guidewires. This crucial limitation, potentially harmful for the patient and the operator, may now be overcome by the use of the PEEK-based MR-compatible guidewire. The guidewire's mechanical properties, such as its good device support capabilities and pushability, are promising, and the floppy wire tip allows atraumatic procedure guidance. The attached paramagnetic markings provide at least acceptable device visibility in gradient-echo sequences. This passivemarker approach allows simple handling of the guidewire and leads to short procedure time. This is beneficial, compared with other more complicated active-tracking approaches (e.g., guidewire receiver coils) applied earlier [16] [17] [18] [19] [20] . The first concepts of automated tracking for passively marked devices have been investigated and may facilitate procedures in the future [21] . Modification of the passive marking's size and thickness may optimize vessellumen contrast and allow marker use according to the diameter of the targeted vessel. The commercially available stents and balloons used in our study were chosen according to target vessel size and product availability.
The OptEase cava filter used in our study is known to be safely usable in the magnetic field [22] . In this study, the filter and its introducer sheath were applied as commercially available without additional MRI markings. This lead to suboptimal visibility of the sheath, through a weak artefact caused by the X-ray-absorbing marker at its tip. For suboptimal visibility of the introducer sheath, sheath positioning was verified in this study through the marker and additional free-hand bolus contrast-media injection through the sheath. Thereby the introducer sheath was safely introduced and precisely positioned over the wire. Because of the atypical deep inflow of the right renal vein in our swine, suprarenal filter placement was performed in the inferior vena cava, which has been shown to be safe and effective in humans [23] .
In the future, application of the described passive markings to balloons, stents, filters, introducer sheaths, and catheters (if needed) may facilitate depiction of such over-the-wire devices for MRI-guided endovascular procedures.
Intravenous application of blood-pool contrast media provides good vascular depiction throughout the interventions. Its higher relaxivity and longer blood half-life (average distribution phase 0.48 hours) compared with standard extracellular MRI contrast medias, may allow endovascular procedure control with a single injection of contrast media in the future [23] [24] [25] .
